Sharon Frey, Ph.D., Professor of Infectious Diseases, Allergy & Immunology, will head one of four vaccine studies to develop a universal flu vaccine, which would protect against multiple virus strains. The study is funded by the National Institute of Allergy and Infectious Diseases at the NIH.

The SLU Vaccine and Treatment Evaluation Unit (VTEU) will conduct the laboratory testing for this phase 2 clinical trial, which will test a vaccine developed by BiondVax Pharmaceuticals.

For more information, read the full article in Newslink.